- VernacularTitle:氨磺必利治疗精神分裂症临床应用专家意见
- Author:
Ying LIANG
;
Dengtang LIU
;
Tianmei SI
;
Yi LI
;
Congpei ZHANG
;
Tao LI
;
Xiufeng XU
;
Chengge GAO
;
Zhimin WANG
;
Li KUANG
;
Qingrong TAN
;
Zhiyu CHEN
;
Shenxun SHI
;
Tiebang LIU
;
Fude YANG
;
Gaohua WANG
;
Jingping ZHAO
;
Kaida JIANG
;
Xin YU
- Keywords: amisulpride; schizophrenia
- From: Chinese Mental Health Journal 2017;31(6):425-431
- CountryChina
- Language:Chinese
- Abstract: Amisulpride,a kind of the second generation antipsychotics,was marketed in China in 2010.A series of clinical research and experience before and after listed,especially the data based on Chinese population,provided evidence for the generalization and application of amisulpride.In order to optimize the clinical application of amisulpride,and improve the prognosis of patients,Expert Advice on the Practical Use of Amisulpride in the Treatment of Schizophrenia is presented here.This advice is based on the recent evidence and clinical experience,for guiding the clinical medication of amisulpride.